Qube Research & Technologies LTD Amylyx Pharmaceuticals, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 789,127 shares of AMLX stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
789,127
Previous 15,600
4958.51%
Holding current value
$5.29 Million
Previous $44,000
3306.82%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
139Shares Held
46.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$28.3 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$22.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$17.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$17.5 Million0.0% of portfolio
-
Abrdn PLC1.97MShares$13.2 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $392M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...